Author(s)

Songül Tezcan, Fikret Vehbi Izzettin, Mesut Sancar, Perran Fulden Yumuk, Serdar Turhal

Clinical Pharmacy Department, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
Oncology Department, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Oncology Department, Faculty of Medicine, Marmara University, Istanbul, Turkey..

Background: To evaluate cisplatin-induced nephrotoxicity in outpatients receiving chemotherapy with cisplatin alone or in combination with other agents using a short hydration method. Methods: Forty-nine patients enrolled in the study were monitored during 3 cycles of chemotherapy. Cisplatin was given in 1000 mL of 0.9% NaCl solution for 90 min as an intravenous infusion. Renal parameters were evaluated before and after each chemotherapy cycle, and 6 weeks after the completion of treatment. Results: Blood urea nitrogen, creatinine, and cystatin C levels increased significantly during the 3 cycles of chemotherapy, whereas sodium and potassium levels decreased significantly. Magnesium and calcium levels decreased only during the second cycle of chemotherapy. Significant increases in uric acid level were observed during the 1st and 3rd cycles, and 6 weeks after the completion of treatment. Conclusions: The method used in our study shows minimal changes in renal functions. To effectively monitor nephrotoxicity, renal parameters and electrolyte levels should be measured before and after each cisplatin based chemotherapy cycle. More investigations are required to evaluate this method with higher doses of cisplatin.

Cisplatin; Nephrotoxicity; Clinical Pharmacy; Oncology Pharmacy; Chemotherapy

S. Tezcan, F. Izzettin, M. Sancar, P. Yumuk and S. Turhal, "Nephrotoxicity Evaluation in Outpatients Treated with Cisplatin-Based Chemotherapy Using a Short Hydration Method," Pharmacology & Pharmacy, Vol. 4 No. 3, 2013, pp. 296-302. doi: 10.4236/pp.2013.43043.